PT-141

Vyleesi label is 1.75 mg as needed, max 8 doses per month. Not a daily cycle peptide.

What it does / how it works

A melanocortin-4 (and MC3) agonist. It acts in the brain on sexual-desire pathways, which is why the approved use is as-needed, not daily. Nausea and a short BP rise are class effects.

Class MC4 / MC3 agonist
Typical vial 10 mg
Reconstitution 1 mL BAC per 10 mg = 10 mg/mL (1.75 mg = 17.5 units)
Storage after mix 2–8°C, use within 28 days

Protocol

Goal Dose How often How long Route
Per use 1.75 mg As needed, at least 45 min before Not a daily schedule SubQ
Monthly cap Do not exceed 8 doses Leave days between uses Ongoing PRN SubQ

Watch: Nausea, flushing, transient BP rise. A 10 mg vial is about five labelled doses.

PT-141 FAQ — Australia

ELV8 Labs offers PT-141 in 10 mg vials, third-party tested at a leading Australian university. For research purposes only.
PT-141 was derived from Melanotan II and is more selective for MC4R. MT-II non-selectively activates MC1R (pigmentation), MC3R, MC4R, and MC5R. PT-141 targets MC4R specifically, producing its primary research effects without significant melanogenic activity.
Published clinical data reports onset of measurable effects approximately 30–60 minutes after subcutaneous administration, with effects lasting 6–12 hours in test subjects.
Published clinical data recommends no more than one dose per 24-hour period and no more than 8 doses per month. This frequency limitation is based on safety and efficacy data from Phase III trials.
Published clinical data recommends no more than one dose per 24-hour period and no more than 8 doses per month. This frequency limitation is based on safety and efficacy data from Phase III trials.

Recommended Supplier — PT-141 Australia

Our products offer premium-grade research materials with independent testing at a leading Australian university. Every batch is strictly verified by RP-HPLC and LC-MS. For research purposes only.

Related Research — Australia

Explore similar research-grade peptides, selected to complement your research needs.

Tesamorelin + Ipamorelin

Tesamorelin target is 1-2 mg daily. Ipamorelin target....

Super Human Blend

One serving: L-Arginine 110 mg, L-Ornithine 110 mg,....

Semax + Selank

Short course. Intranasal preferred. Then 2-4 weeks off.....

Retatrutide + Cagrilintide

5+5 mg is a late stock, not a....
Select your currency
AUD Australian dollar